Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention.
While dietary habits continue to surface as a significant factor that may influence cancer incidence and tumor behavior, there is considerable scientific uncertainty about who will benefit most. Adequate [corrected] knowledge about how the responses depend on an individual's genetic background (nutrigenetic effects), the cumulative effects of food components on genetic expression profiles (nutritional transcriptomics and nutritional epigenomics effects), the occurrence and activity of proteins (proteomic effects) and/or the dose and temporal changes in cellular small molecular weight compounds (metabolomics effects) will [corrected] assist in identifying responders and non-responders. Expanding the information about similarities and differences in the "omic" responses across tissues will not only provide clues about specificity in response to bioactive food components but assist in the identification of surrogate tissues and biomarkers that can be used for predicting a response. Deciphering the importance of each of these potential sites of regulation will be particularly challenging but does hold promise in explaining many of the inconsistencies in the literature.
Davis
Cindy D
CD
NIH/NCI, Nutritional Sciences Research Group, 6130 Executive Blvd, MSC 7328, Rockville, MD 20892-7328, USA. davisci@mail.nih.gov
Milner
John
J
D016588:Anticarcinogenic Agents / Q000494:pharmacology; D004032:Diet; D006801:Humans; D009369:Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000517:prevention & control*; D009747:Nutritional Physiological Phenomena; D020543:Proteome
D016588:Anticarcinogenic Agents; D020543:Proteome